language_icon
EN
HI

Vineet Laboratories Share price

VINEETLAB

34.1

0.17 (-0.50%)
NSE
BSE
Last updated on 2 Jun, 2026 | 12:41 IST
Today's High

34.90

Today's Low

33.20

52 Week Low

23.91

52 Week High

43.50

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Vineet Laboratories Chart

Vineet Laboratories Share Key Metrics

Volume
19709.00
Market Cap
65.82 CR
LTQ@LTP
100@34.10
ATP
34.51
Var Margin
100 %
Circuit Range
32.56-35.98
Delivery %
0 %
Value
6.80 L
ASM/GSM
No
Market Lot
1

Summary

Vineet Laboratories share price is ₹34.1 as of 2 Jun, 2026. The stock Vineet Laboratories intraday movement has stayed between ₹33.20 and ₹34.90, while on a 52-week basis,Vineet Laboratories price 52 week high is ₹43.50 & its 52 week low is ₹23.91.
In terms of trading activity, Vineet Laboratories has recorded a volume of 19709 shares, The Vineet Laboratories has a market cap of ₹19206266 CR. The stock’s Average Traded Price (ATP) stands at ₹34.51, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 100 @ ₹34.10.
Vineet Laboratories operates within a circuit range of ₹32.56 – ₹35.98, with a Value of ₹6.80 L. The Delivery Percentage for the day is 0%. Additionally, Vineet Laboratories currently falls under the No framework, and trades with a market lot size of 1.

Vineet Laboratories Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

69.53

Sector P/B

2.99

Sec. Div. Yield

0.55

Vineet Laboratories Resistance and Support

Pivot 34.09

Resistance

First Resistance

35.07

Second Resistance

35.86

Third Resistance

36.84

Support

First Support

33.3

Second Support

32.32

Third Support

31.53

Vineet Laboratories Shareholding Pattern

View More
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

5.98%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0.36%

Domestic Institutional Investors

0%

Retail

93.66%

Others

0%

Total Promoters
MAR '26
5.98%

Vineet Laboratories Corporate Actions

DateAgenda
2026-05-30Audited Results
2025-07-22Quarterly Results
2025-05-12Audited Results

Vineet Laboratories News

Vineet Laboratories Limited

Vineet Laboratories Board meeting on May 30, 2026, deferred the consideration of audited standalone financial results for Q4 & FY26. The deferral was due to the Audit Committee not having considered or recommended the results. Additionally, the Company Secretary and Compliance Officer resigned.
May 30 2026 23:11:44

Vineet Laboratories Ltd - 543298 - Outcome Of Board Meeting Held On May 30, 2026 - Deferment Of Consideration Of Audited Standalone Financial Results

Vineet Laboratories deferred the consideration of its Q4 & FY26 audited standalone financial results, citing the Audit Committee's failure to consider and recommend them. Concurrently, the Company Secretary and Compliance Officer resigned. This indicates potential internal control and governance concerns.
May 30 2026 23:01:32

Vineet Laboratories Limited

Vineet Laboratories Limited's board will convene on May 30, 2026, to consider and approve the audited standalone annual financial results for the year ended March 31, 2026. This meeting serves as a key update for the company's financial performance.
May 26 2026 19:07:29

Vineet Laboratories Ltd - 543298 - Board Meeting Intimation for To Consider And Approve The Audited Standalone Financial Results Of The Company For The Fourth Quarter And The Financial Year Ended March 31St, 2026.

Vineet Laboratories board will convene on May 30, 2026, to review and approve the audited standalone financial results for the fourth quarter and financial year ended March 31, 2026. This meeting will determine the company's annual performance.
May 26 2026 19:05:55

Vineet Laboratories Ltd - 543298 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Vineet Labs' Monitoring Agency Report for the quarter ended March 31, 2026, confirms utilization of Rights Issue proceeds for stated objects. However, Rs. 16.43 crore remains unutilized, and there are delays in projects like the Effluent Treatment Plant and new production facility due to timing of fund receipt. The company plans to get revised deployment approved.
May 15 2026 20:16:25
Read More

Vineet Laboratories Management

NamePosition
Ramesh BandariCompany Secretary & Compliance Officer
Dilip Vishnu AcharekarChairman
View More

Vineet Laboratories FAQs

The Buying Price of Vineet Laboratories share is 34.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Vineet Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Vineet Laboratories, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Vineet Laboratories shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Vineet Laboratories shares is 0. Useful to assess the stock's value relative to its book value.

To assess Vineet Laboratories’s valuation compare Sector P/E, P/B which are 69.53 & 2.99 with sector averages, along with growth rates and financial metrics.

The Market Cap of Vineet Laboratories is 65.82 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Vineet Laboratories share price is 43.50 & 23.91. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Vineet Laboratories belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost